Medscape |
Tumor Profiling Panel Undergoes Simultaneous FDA, CMS Review
Medscape The US Food and Drug Administration (FDA) has approved a cancer diagnostic test, FoundationOne CDx (F1CDx, Foundation Medicine), for use in detecting 300-plus genetic mutations in any solid tumor. At the same time, the Centers for Medicare & Medicaid ... FDA approves one-of-a-kind cancer gene test Will Foundation's FDA, CMS Nod Help Cancer DNA Tests Break Through? FoundationOne CDx Granted FDA Approval, CMS Agrees to Provide Coverage |
from Health - Google News http://ift.tt/2Akup5X
EmoticonEmoticon